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Abstract

Problem: The U.S. Pharmacopeia (USP, 2016) Convention Chapter 800: Hazardous Drugs:
Handling in Healthcare Settings took effect on December 1, 2019. According to Polovich and
Olsen (2017), “The implementation of the USP <800> Standards will represent an important step
forward to protect nurses and other potentially exposed health care workers (HCWs)” (p. 1).
Context: The Doctor of Nursing Practice (DNP) project implemented a hazardous drug (HD)
safe-handling personal protective equipment (PPE) toolkit in accordance to USP<800> standards
and hospital policies at an ambulatory cancer infusion center to improve nurses’ adherence with
PPE use.
Interventions: The project consisted of (a) a safe-handling PPE toolkit, (b) a PPE observation
tool, (c) an expert panel discussion, (d) a nurses’ skills session, (e) an online safe-handling
survey, (f) an HD safe-handling checklist, and (g) a performance dashboard.
Measures: Outcome measures included (a) 90% or higher compliance rate with PPE use during
HD administration and (b) sustained adherence to USP <800> standards and hospital policies by
February 2020.
Results: A 90% compliance rate for PPE use during HD administration was achieved by
February 2020. Sustainability is at risk due to the COVID-19 pandemic and global PPE shortage;
however, nurses were able to adapt to new processes to conserve vital resources.
Conclusions: A systems-thinking approach to the implementation of USP <800> standards for
HD safe handling was successful in improving compliance and adherence to PPE use among
ambulatory infusion nurses.
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Section II: Introduction
Problem Description
In 2016, the National Institute for Occupational Safety and Health (NIOSH) reported
more than eight million healthcare workers (HCWs) in the United States are potentially exposed
to hazardous drugs (HDs). HCWs with long-term, low-level occupational exposure have shown
an increased risk of adverse reproductive outcomes and other life-threatening health issues
(Connor et al., 2014; Hon et al., 2014). Adverse health outcomes include genetic changes, cancer
development, congenital disabilities and fetal abnormalities, organ toxicity, and infertility,
among others. McDiarmid and Condon (2005) reported a 20% increase in chromosomal
abnormalities in exposed HCWs who had a moderate level of HD handling (>100 handling
events of chemotherapy within six weeks). Lack of dynamic organization and worker
accountabilities and poor oversight of HD handling resulting in environmental contamination
have caused irreversible harm and death in some cases (Smith, 2010).
Healthcare organizations have prepared for the implementation of the USP Chapter 800:
Hazardous Drugs-Handling in Health Care Settings (USP <800>) since 2016, whereby stricter
regulatory standards provide enforceable safe-handling protections for all HCWs to minimize the
risk of HD exposure (U.S. Pharmacopeial Convent [USP], 2016). As USP <800> preparations
evolve, enhanced organizational efforts to educate staff and enforce compliance measures are
driving new worker safety practices across health systems in the United States (Andrews & Dill,
2018). Despite scientific evidence of known exposures and adverse health outcomes to HCWs,
resistance to personal protective equipment (PPE) use during HD handling continues.
Researchers from NIOSH and the Harvard T. H. Chan School of Public Health, Harvard
Medical School, and Brigham and Women’s Hospital in Boston, Massachusetts, reported survey
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data from 40,000 American and Canadian nurses, ages 29 to 49 years, who participated in the
Nurses’ Health Study 3 since 2010 (Burdick, 2019). Researchers reported that 12% of nonpregnant nurses and 9% of pregnant nurses indicated they did not wear gloves when
administering antineoplastic drugs. Forty-two percent of non-pregnant nurses and 38% of
pregnant nurses did not use a gown. About one in 10 nurses during their first 20 weeks of
pregnancy did not always wear gloves, and one in two did not always wear a protective gown
when administering HDs. According to Hennessy and Dynan (2014), “Resistance is based on a
denial of risk, insufficient information, lack of policy enforcement or regulation, or lack of
provision of safe-handling devices” (p. 497). Sadly, toxic HD residues found on healthcare
surfaces have now infiltrated the home surfaces of treated patients, exposing cohabitants, family
pets, and the community environment (Bohlandt et al., 2017; Connor et al., 2016; Yuki et al.,
2013).
Ambulatory care infusion nurses have not fully adopted policy efforts that changed PPE
use from guidelines to mandatory requirements through the implementation of USP <800>. The
primary reason for implementing this evidence-based practice (EBP) initiative was two-fold: (a)
USP <800> requires HCWs to wear PPE when handling HDs, and (b) HD policies must be
strictly followed to meet USP <800> standards to improve HCW safety. The quality
improvement (QI) intervention’s aim is to ensure that infusion nurses are prepared to follow the
new USP <800> standards and to provide a PPE resource toolkit to improve HCW safety.
The project took place in an ambulatory infusion center (AIC) setting. The AIC has 36
infusion treatment chairs utilized primarily by oncology patients receiving intravenous (IV)
chemotherapy. However, patients may also receive chemotherapy for non-oncologic health
problems. The study involved the observation of experienced infusion nurses, defined as having

8
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two or more years in HD administration, to determine the baseline adherence rate of PPE use
with HD handling after nurses completed an online self-assessment survey. All nurses carry a
chemotherapy and biotherapy certification card that indicates sufficient training and competence
in the area of HD administration and drug knowledge. The first goal was to have 100% of the
surveys returned and to observe at least 90% of the nurses prepare, administer, and dispose of
HDs over four weeks. Ten nurses were eligible to participate in the QI project. Since policies
specific to PPE requirements with HD handling were being revised by the organization, approval
was given to use the most current HD policy until the 2020 policies became available.
Available Knowledge
PICOT Question
The following PICOT question was formulated to guide a literature search for evidencebased solutions: Would the development of an HD safe-handling PPE toolkit improve infusion
nurses’ compliance and adherence with PPE use during HD handling and improve compliance
with USP <800> standards and hospital policies for HD handling by February 1, 2020?
Literature Review
The Doctor of Nursing Practice (DNP) student conducted a literature review using
CINAHL (Cumulative Index to Nursing and Allied Health), Cochrane Library, and PubMed
databases to locate information on recommendations to improve PPE use in nurses. More than 50
studies and articles from 2015 to 2019 were located in the search, with 15 selected for further
review (see Appendix A). Findings demonstrated a clear and present danger regarding HD
exposure and the need to consider mandatory EBP interventions and environmental oversight in
the workplace. Excluded articles were those that focused on hospital HD administration, routes
of administration of HDs other than IV, anesthesia HDs, and occupations outside the healthcare
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setting. Keywords for the search included hazardous drugs, occupational health, protective
equipment, safety standards, and USP <800>.
Final literature selection criteria were determined after analyzing the strengths,
weaknesses, limitations, and quality of evidence using the Johns Hopkins Nursing EvidenceBased Practice Tool (Dearholt & Dang, 2016). There were five Level 1A, four Level IIA, and six
Level IIIA quality ratings for the selected articles, which represents a quality approach for
selecting evidence to address the problem. The articles and research studies identified three
themes: (a) HD residues found in patient homes after treatment, (b) organizational safety culture
responsibilities, and (c) nurses’ attitudes and behaviors toward PPE use must change from
complacency to corrective action for personal and public safety.
Summary of Evidence
First, there is no safe level of HD exposure reported in the literature by the experts.
Several research studies shed light on the issues surrounding involuntary HD exposure. One
study, presented by Yuki et al. (2013), tested the urine of family members of three cancer
patients who received at least one of two antineoplastic drugs (cyclophosphamide [CP] and
fluorouracil [5-FU]) during the first 48 hours after chemotherapy treatment and found detectable
levels of CP exposure. Swipe tests of common household surfaces showed contamination of HD
residues inside the homes, confirming that low-level exposure is possible and must be further
studied.
Bohlandt et al. (2017) conducted an environmental and biological study inside 13 homes
of treated cancer patients and confirmed HD residues on household surfaces. The researchers
obtained 265 swipe samples in the homes and found that toilets, floor and sink handles, and
kitchen surfaces had measurable levels of HD residues left behind by treated patients. Crickman
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and Finnell’s (2016) systematic literature review determined that HCWs were at high risk of
exposure, which included caregivers who were not responsible for medication administration but
cleaned up after a treated patient. The main concern was about family member exposure risks
because they often become the primary caregivers after chemotherapy treatments. PPE selection,
HCW competencies, increased oversight, and medical monitoring of high-risk personnel were
highlighted as critical strategies to prevent and manage involuntary exposure in the work
environment.
Clark et al. (2014) developed a field study investigating the influence of role definitions
on the association between safety climate and employees’ organizational citizenship behavior.
Providing safe working conditions requires a significant commitment on the part of leadership
and stakeholders. Unfortunately, an organization’s obligation to provide safe working conditions
can be overshadowed by conflicting priorities and budgetary constraints. However, Clark et al.
stated that nurses who felt supported and protected are more likely to go above and beyond
expectations to provide patient care.
He et al. (2017) completed a cross-sectional, multi-state survey offered to Oncology
Nursing Society (ONS) members (N = 654) to examine whether the organization’s safety culture
correlates to nurses’ use of PPE. The study involved nurses working in ambulatory care centers
in three states in the United States. Nurses self-reported perceptions of low risk to HD exposure,
limited PPE availability, and workload demands that may influence compliance with safety
measures. He et al. suggested that nurse managers actively monitor and adjust nurse/patient
ratios, ensure that supplies are readily available, and provide ongoing PPE training.
The most recent study by Friese et al. (2019) concluded that despite decades of research,
PPE use remains suboptimal and suggested that professional organizations, policymakers,
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clinical experts, and health systems align to guide best practices. Friese et al. recommended that
nurse educators standardize curriculum and reinforce personal accountability regarding safe
handling and PPE use. Unfortunately, efforts to improve adherence through learning modules
and self-report questionnaires failed to change nurses’ behaviors and attitudes about PPE use (N
= 396).
DeJoy et al. (2017) examined predictors of PPE use, safe-handling components, and
adverse events associated with HD exposure in nurses (N = 1,814) and concluded that adherence
to guidelines is inconsistent. Interestingly, PPE use was worse and less predictable among more
experienced nurses. The study assessed the safety climate, nurses’ perceived safety culture with
PPE, engineering controls, and adverse events with IV HDs. A comprehensive health and safety
program emphasizing hazard controls was suggested to promote safe behavior and compliance
among all HCWs (DeJoy et al., 2017).
Research conducted in ambulatory oncology practices supports stricter, even mandatory,
PPE utilization and endorses environmental and biological monitoring for the detection of
harmful residues (Bohlandt et al., 2017). Recommendations for HD controls focus on better
engineering controls, such as closed-system transfer devices (CSTDs) and biologic safety
cabinets; administrative controls, such as policies and procedures and access to information;
work practice controls, such as acuity-based scheduling and reducing workloads; and compliance
enforcement. Most importantly, nurses are aware of the hazards associated with exposure, but
continue to exhibit risky behavior (Bohlandt et al., 2017).
Rationale / Conceptual Framework
The Orem model of nursing, or self-care deficit nursing theory, was developed by nursing
theorist Dorothea Orem and covered a broad spectrum of general concepts for nursing
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consideration and application (Alligood, 2014). The theory is comprised of three related parts:
(a) the theory of self-care, (b) the theory of self-care deficit, and (c) the theory of nursing
systems. Some of the theory’s relativity to this project include: a person’s knowledge of potential
health problems is needed for promoting self-care behaviors, the prevention of hazards to human
life and wellbeing, and the responsibility for their care, as well as others who require care. This
model depicts how health professionals have as much of a responsibility to care for themselves
as they would care for others (Vincent et al., 2016; Younas, 2017).
Donabedian’s conceptual model, developed in 1966, provides a framework for
developing, implementing, and evaluating this intervention (McDonald et al., 2007). Applying
the components of the model includes the assessment of the structure, process, and outcomes
relative to ambulatory infusion centers associated with the management of HDs. According to
Donabedian, the physical setting would be the cancer center. The elements would include the
mission, vision, and values of the organization; leadership skills; staff knowledge; adequate
staffing and scheduling; well-designed workspace; and patient population. Other elements to
support a safety culture include having the proper equipment to perform the tasks involved.
The process includes interventions to safely deliver HDs, such as highly trained oncology
infusion nurses. Developing standard work and tip sheets that specify the steps for each stage of
handling would be considered process outcomes. Evidence-based guidelines and regulatory
mandates affecting HCWs and patient safety are outlined in the USP <800> standards. Finally,
an outcome is a final product combining both structure and process. A favorable outcome would
have a sustainable structure and process that reduces the risk of HD contamination at all stages of
HD handling and HCW adherence to PPE policy requirements. Poor outcomes allow for failures,
such as inconsistent PPE use or other risky behaviors by HCWs contrary to EBP
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recommendations. Other relevant outcomes include improved patient perception of safety
captured in patient satisfaction surveys and reduced costs associated with employee monitoring
for HD exposures. Nurses’ attitudes and perceptions about self-preservation will become the
norm and align with policies and procedures meant to protect the population.
Specific Aims
The objectives were to develop an HD safe-handling PPE toolkit to learn if infusion
nurses’ adherence to PPE use would improve to 90% or higher with HD handling and comply
with the USP <800> standards and hospital policy by February 1, 2020. The specific aims were
to determine if (a) based on direct observation, nurses comply with USP <800> requirements and
hospital policy when administering and disposing of IV chemotherapy; (b) based on nurse selfassessment, PPE standards and hospital policy were followed at least 90% of the time; and (c) if
any differences are noted in nurses observed and self-assessed adherence to PPE standards and
hospital policy. If differences were noted, additional peer-to-peer coaching would be considered
until 90% compliance had been reached.
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Section III. Methods
Context
PPE is critical for handling HDs at every step in the process. The AIC nurses require
systematic training on PPE selection, donning and doffing, and disposal of contaminated
materials to improve compliance with hospital policy. According to Friese et al. (2019),
“Education and engagement of nursing personnel are not sufficient to improve PPE use.
However, systematic approaches may result in improved practice” (p. 255). The intervention
included the development of an HD safe-handling PPE resource toolkit to help guide best
practice, according to Friese et al.’s recommendations.
The key stakeholders included the AIC staff, the assistant unit manager (AUM), the
cancer center executive director, the director of clinical oncology services, the cancer committee,
and the environment of care workstream group. The USP <800> committee provided a systemsthinking perspective, as the project results may apply to other affiliated AICs. The cancer
committee approved this project as one of its QI initiatives for 2019. The project meets the
Commission on Cancer Accreditation’s 2019 Program Standard 4.8 (quality improvements).
Finally, USP <800> standards enforce organizational compliance with all applicable HD
requirements.
Intervention
The DNP project was conducted in an AIC adjacent to a large tertiary medical center
campus. The staff consists of 15 registered nurses, two patient care associates, one AUM, and a
unit secretary. Only 10 nurses were eligible to participate because of their years of experience in
oncology (> 2 years). The five excluded nurses included one nurse retiring, one nurse on

USP <800> AND THE PPE PROJECT

16

maternity leave, and three nurses with less than one year of infusion experience. The AIC is open
seven days per week, and nurses generally work 10-hour shifts from 8:00 a.m. to 6:30 p.m.
The interventions were implemented after approval from the hospital’s Internal Review
Board (IRB) on October 6, 2019 (see Appendix B and Appendix C), but preliminary project
planning began in June 2019. A Statement of Non-Research Determination was presented and
approved by the University of San Francisco’s (USF) DNP committee. The project began on
September 15, 2019, and ended on March 31, 2020. Upon completion, the revised HD policy
became available and required the DNP student to review changes with all AIC staff. The
interventions consisted of:
•

Introduction of HD safe-handling PPE toolkit

•

PPE observation tool (Hennessy & Dynan, 2014)

•

Observations of chemotherapy safe-handling adherence tool

•

PowerPoint discussion

•

PPE skills session at annual skills day

•

Safe-handling adherence between observation and self-assessment survey

•

HD administration safe-handling peer-to-peer checklist

•

Use of performance dashboard

Gap Analysis
Better access to education is needed to ensure that employees are fully aware of the risks
of adverse health consequences from HDs (Boiano et al., 2014). Gaps specific to the AIC
included scheduling demands and workload pressures facing nurses in the unit. For example,
nurses were scheduled 10 to 12 patients per 10-hour shift. After a literature review revealed that
the number of patients assigned per nurse/per day significantly influenced total HD precautions,
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scheduling templates were redesigned to accommodate six to eight patients per shift
(Mendelsohn-Victor et al., 2017). Acuity levels for all therapies were reconfigured, and the
adjusted levels went from 25 acuity points per day to 20 acuity points per day. Fewer patients per
nurse, with balanced acuity levels, is the goal; yet. both can change dramatically throughout the
workday, jeopardizing real-time safety.
The lack of access to PPE supplies and environmental constraints contributed to the lack
of willingness by nurses to change behavior on their own. Approximately 90% of the time, all
required PPE was unavailable in the unit. This included shortages of chemo-protective gowns,
booties, face shields, and eye protection. Structural changes were done to reduce barriers in some
cases (see Appendix D. Gap Analysis). Not all exposure risks involve nursing practice; each step
in the handling process should be managed appropriately. EBP, policies, and procedures;
engineering controls; unit-based workplace designs; and the HCWs’ commitment to improving
safety must guide processes and outcomes (Callahan et al., 2016).
Gantt Chart
The execution was divided into four phases, as outlined in the Gantt chart (see Appendix
E). Phase one began on September 15, 2019, before formal IRB approval, as the organization’s
USP <800> committee was working on the PPE requirements and invited the DNP student to
join the group. Written organizational IRB approval was received on October 6, 2019; however,
verbal approval was given on September 15 to begin the QI preparations. The cancer committee
pre-approved the project in June 2019 at their quarterly meeting. Nurses were provided an online
survey platform called SurveyMonkey to access a self-assessment of a safe-handling
questionnaire in the second phase. A PPE observation tool was used to evaluate nurses’ actual
compliance over two weeks following the survey. The third phase provided nurses with
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information about USP <800> standards for PPE via PowerPoint presentation, PPE skills
demonstration, and the HD safe-handling toolkit at a staff meeting in December 2019. Phase four
began January 15, 2020, and included peer-to-peer feedback for identified problems during the
observation phase. Data collection was being done as the USP <800> committee finalized the
HD policies and procedures for the organization. The DNP student oriented the nurses to the new
policy changes and toolkit location on the intranet.
Work Breakdown Structure
The purpose of the work breakdown structure (WBS) is to have a plan and infrastructure,
supporting documentation and metrics tools, comprehensive education strategies, and a
monitoring plan to maintain fiscal responsibility and increase chances of sustainability for the
intervention (see Appendices F, G, H). Since the organization has been proactively preparing for
USP <800> since 2016, this project served as an adjunct to other administration processes
requiring PPE changes and ensured that the cancer center was included in the workgroups.
There are five phases of development in the WBS: initiation, planning, execution, control, and
close-out.
During the initiation phase, the project manager attended various USP <800> workgroups
to share information about the proposed DNP project and to elicit recommendations specific to
requirements for IRB approval. All committees approved the project plan. A preliminary scope
statement was completed, and the final project plan was shared with the cancer committee for
final approval at their quarterly meeting. The execution phase included a kickoff meeting
verifying USP <800> PPE requirements and introducing the toolkit purpose and design, PPE
needs, and testing processes. Staff training and the go-live date were coordinated with the
manager. The control phase of the WBS included project management, project status meetings,
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risk management, and updating the project management plan. Finally, the close-out phase was
one of the essential aspects of the project. An audit procurement and lessons learned session is
instrumental because all of the completed steps were analyzed and reported to the committees.
All files and records were collected and archived. Portions of the toolkit were placed on the
intranet for all employee access during work hours under the heading “Resources” and
“Hazardous Drug Administration.”
SWOT Analysis
The SWOT analysis (strengths, weaknesses, opportunities, and threats) is a useful tool for
identifying the factors impacting the success of the project (see Appendix I). The major strength
is that the organization was using a systems-thinking approach to implement the USP <800>
standards before the February 1, 2020, deadline. Executive leadership and frontline managers
worked together to address issues found in the gap analysis and made adjustments. Par levels for
PPE were adjusted with central supply chains. Standards of practice were aligned across the
health system to improve communication regarding PPE use.
The most significant weakness was the nurses’ reluctance to wear PPE. Even after
focused training and reminders, nurses remain complacent (Friese et al., 2019). Without
addressing the negative attitudes about PPE use, improving safety will remain unsustainable.
Opportunities to comply with USP <800> specific to PPE use are also receiving attention from
the public, as exposure to HDs becomes a threat to patients in the home and in community
settings. The increase in demand for more comprehensive patient education and internet searches
calls for nurses to step up to the challenge.
The significant threats external to the organization may be associated with the high cost
of equipment (PPE), HCW health monitoring, and recruitment and retention of qualified infusion
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nurses. Also, there may be a loss of funding in the coming years for healthcare programs that
strive to meet the demands of the 21st Century Cures Act. This legislation will increase Medicare
infusion access to eligible patients and impose significant financial disincentives to home
infusion pharmacy services. PPE and waste management strategies must remain part of the new
legislation to prevent the dumping of chemical waste into communities and to ensure access to
appropriate PPE for nurses.
Responsibility / Communication Matrix
The QI project complimented a USP <800> workstream that existed to address the
readiness of ambulatory care units by providing expertise and guidance and by addressing the
unique needs of AIC staff requiring PPE for chemotherapy administration (see Appendix J). The
cancer committee required updates in order to satisfy a 2019 QI initiative for accreditation. A
smaller workgroup oversaw the procurement of PPE and reported the potential financial impact
on the organization. Training AIC nurses required thoughtful efforts to minimize anxiety and
stress to staff and their patients. The DNP student used a systems thinking process to ensure
communication between all parties and to ensure the fair use of time and resources.
Cost / Benefit Analysis
The need to evaluate the costs associated with establishing HD training and adequate par
levels for PPE was realized early on and related to the complexity of the organization and work
stream processes necessary to accomplish system wide implementation. Specific to the AIC, the
training of staff on HD administration and PPE use was estimated to be around $3,425. In
addition, the DNP student’s contribution of 215 hours was factored in at around $17,200. The
PPE supplies and other available resources was grossly underestimated at $7,350 per week. This
estimate was difficult to ascertain because the supplies were bundled into facility costs within the
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current budget system. However, individually purchased PPE items were extracted directly from
a list provided by central supply services upon request. A discussion about where to store the
toolkit, whether desktop or on the intranet, would determine the actual cost of providing up-todate HD resources and tools for all staff in high-risk areas. Structural changes and additional HD
waste management containers were also required before project implementation to ensure that
access to safe disposal of HD waste could be accomplished.
According to the Workers Compensation Insurance Rating Board (WCIRB, 2017), the
2017 California indemnity claim averaged $37,054, which was the 5th highest-reported claims
cost in the United States. The average claim is 40% higher than the median average nationwide.
With this cost risk in mind, and applying it to 10 HD exposed nurses, the cost for one year of
treatment and surveillance would be more than $370,540 per year. The average California claim
is reported as paid over three years, at a cost of $1.1 million for 10 potentially exposed nurses.
The organization is self-insured and utilizes internal services to provide care to employees who
have been affected in order to reduce the burdens associated with the adverse effects of HD
exposure on health and wellbeing. The benefits of implementing an HD safe-handling program
far outweigh the costs associated with care required for adverse consequences.
The AIC is a high utilizer of PPE, and essential cost factors were not realistic in the 2019
budget. With 2,800 patient visits per month expected in 2020, the costs of providing PPE to
nurses for 80% of patients are daunting. The projected annual costs for PPE procurement will be
increased by 20% in the upcoming 2020 budget. The increased costs do not include unforeseen
events associated with flu season or potential pandemic situations. Non-monetary benefits
include ethical, moral, and harm reduction efforts to protect staff and patients and cannot be
quantified into a dollar amount. The budget estimates document depicts financial projections for
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implementing the project (see Appendix K, L, and M). The toolkit will be placed on the intranet
and will not require printing, as previously planned.
Study of the Intervention
The PPE observation tool was used to collect pre-intervention data to evaluate the current
state of adherence to PPE use with HD administration. To assess observations of handling,
administering, and disposing of chemotherapy, a 15-item yes or no nurse skill checklist was
used. To retrieve self-assessments of nurses’ adherence to PPE use and to follow hospital
policies, a 15-item questionnaire, using a 5-point Likert scale response set, ranging from 0
(never) to 4 (always) plus a not-applicable option, was designed on SurveyMonkey. Also
collected and analyzed were the nurses’ professional characteristics through the self-assessment
survey questions using checkbox and fill-in-the-blank responses.
Analysis
Data analysis involved describing the nurse skills checklist frequencies and selfassessment of RN characteristics using medians and quartiles of counts and percentages for all
categorical variables. Mean scores for the 15-item self-assessment questionnaire on PPE use
were calculated by averaging responses across administration, disconnection, and disposal of
chemotherapy. After matching factors for the nurse skills checklist and self-assessment
questionnaire, data were compared to learn if differences exist in adherence to PPE and hospital
policies for safe handling.
Ethical Considerations
One of the core Jesuit values is forming and educating agents of change, which means
teaching behaviors that reflect critical thought and responsible action on moral and ethical issues.
Infusion nurses must change attitudes and behaviors about PPE use because of the high-risk
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nature of harm with HD contamination. It is morally and ethically irresponsible to subject others
to harmful toxins because of one’s actions. This evidence-based improvement project, suggestive
of individualizing the care and attention to HCW safety, was also intended to promote patient
safety and maintain the highest standards of care, in accordance with the Jesuit values for all
people and the environment.
The American Nurses Association’s (ANA, 2015) ethical standard that relates to this
EBP project is Provision 3, “The nurse promotes, advocates for, and protects the rights, health,
and safety of the patient” (p. 9). Provision 3.4 of the ANA Code of Ethics states that nurses have
a professional responsibility to promote a culture of safety. This provision extends beyond
reporting events and errors that occur to patients and includes “adherence to policies that
promote patient health and safety” (ANA, 2015, p. 12). This project empowers nurses to
establish habits that protect patients from involuntary HD exposure. Efforts were made to
minimize the psychological stress nurses and patients may have felt while participating or
observing the intervention by informing them of the new safety regulations in place to increase
safety in the AIC.
On September 1, 2019, the USF DNP department determined that this project met the
guidelines for an evidence-based change in practice project, as outlined in the DNP project
checklist (statement of determination) and was approved as non-research. There are no
identifiable issues or conflicts of interest noted for this project. On October 6, 2019, the IRB of
the healthcare organization also approved the request to move forward with the project (see
Appendix B). As a non-research project, the IRB approved its implementation. The QI initiative
was also an improvement endeavor through the University of San Francisco’s Professionals (see
Appendix N).
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Section IV. Results
The purpose of this section is to describe the results obtained from the tools developed to
improve AIC nurses’ compliance and adherence to PPE use during chemotherapy handling. The
initial survey assessed the personal demographics of respondents related to the practice of
nursing, as well as individual practices and behaviors associated with the administration of IV
antineoplastic drug administration in the AIC setting.
Surveys
Responses to Survey
A total of 10 surveys were completed from an eligible group of 10 registered nurses. The
initial survey request was not well-received, so another attempt was made, yielding all 10
possible survey responses (100% return). All participants reported two or more years of
oncology experience, possession of a chemotherapy and biotherapy card, and that their position
required the handling, administration, and disposal of IV chemotherapy and HD waste. No
missing data were noted, as the survey was set up via SurveyMonkey so that respondents could
not skip any questions. Most participants were middle-aged (range = 25 years to 68 years, SD =
14), with an average age of 44 years. Seven of the 10 nurses had earned their Oncology Certified
Nursing (OCN) credential (70%) and reported they were members of the Oncology Nursing
Society [ONS] (70%). Most staff worked 10 hours per day, and the average caseload managed
per day for chemotherapy and non-chemotherapy treatment was 10 (range = 5 to 12, SD = 1.84).
Descriptive Statistics
The tables in Appendix O display the descriptive statistics. Sample demographics are
displayed in Table 1. Table 2 shows the results of the Nurses’ Self-Assessment of Adherence to
the Chemotherapy Safe-Handling Survey. Table 3 displays Observations of Chemotherapy Safe-
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Handling Adherences in Number of Events. Table 4 displays Differences between Nurses’ SelfAssessment of Adherence from Survey and Direct Observation of Adherence.
Handling and Administration
Fifty percent of nurses reported using absorbent pads on work surfaces for chemotherapy
agents, but only 32% were observed doing so (n = 50 events). All scores in the handling and
administration category were below the 90% threshold of adherence to hospital policy on HD
safe handling. However, nurses scored themselves lower in all categories than what was
observed. It is possible that after the nurses took the self-assessment survey, they considered
some of the actions worthy of immediate practice adoption and change.
Disconnecting and Discarding
None of the nurses stated that they wrapped a gauze pad around the connection (CSTD)
when disconnecting chemotherapy tubing, leaving the chemotherapy bag attached. An 8%
improvement in practice was observed after the survey was completed. There were two other
discrepancies noted between the self-assessment and observation results that were concerning.
Nurses reported that 90% of the time, gloves were disposed of in a chemotherapy-approved
container. Seventy percent of nurses reported washing hands after disconnecting chemotherapy.
Only one observation met the 90% threshold, which indicated that chemotherapy was discarded
with the attached tubing into a chemotherapy-approved waste container. Nurses also selfreported a 10% compliance with wearing two pairs of chemotherapy-approved gloves and
chemotherapy-approved gown when handling chemotherapy.
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Section V. Discussion
Summary
The purpose of this section is to provide a summary of results obtained from the QI
project done in the hospital’s outpatient AIC located in the cancer center. This section explains
the role of the DNP-prepared clinician as it relates to the application of the project. Furthermore,
the project aims, key findings, lessons learned, and how the project contributed to improving the
compliance and adherence to USP <800> and hospital HD policies and procedures related to
PPE use are presented.
Although the health risks of HD exposure are well documented, AIC nurses reported
suboptimal overall adherence to safe-handling precautions when administering chemotherapy.
These findings are consistent with the literature, as they reinforce that recommended practices,
despite the availability of published safety warnings by professional organizations such as the
ONS, NIOSH, and others, are inconsistent (Boiano et al., 2014; Polovich & Olsen, 2017).
According to the Safe-Handling Adherence between Observation and Self-Assessment results,
the use of double-gloving and donning/doffing PPE were rarely used by AIC nurses before the
intervention. The PPE toolkit was introduced and outlined specific PPE-wear in multiple
scenarios, including oral chemotherapy administration (see Appendix P).
The project aims were achieved, in that nurses’ understanding of the purpose of USP
<800> standards improved, compliance and adherence to PPE use improved, and hospital HD
policies were followed. PPE use also may have improved as supplies became more accessible in
the patient treatment areas and were restocked routinely by central supply services. One critical
lesson learned was that unit culture matters. The nurses who were late adopters in wearing PPE
criticized participating nurses as being wasteful of valuable resources. Nurses did not hold each
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other accountable for nonadherence. However, the USP <800> standards seemed to be the
driving force for improving compliance and adherence for both the organization and the AIC
staff. The AUM also had leverage to discipline staff who failed to follow the new policy
mandates now published throughout the organization.
Unfortunately, competing priorities due to the COVID-19 pandemic in March 2020
affected the availability of PPE supplies around the world. During the shortage, the ONS (2020),
at the request of its members, developed a position statement on PPE use and provided
alternative solutions for infusion nurses to conserve resources. While this was not ideal, nurses
felt healthcare providers on the frontlines of treating COVID-19 infected patients should receive
priority. Staff returned to old habits and ignored policy mandates, mostly because of unit culture
acceptance, a lack of PPE availability, and because there was little chance to comply with all the
new requirements fully. A post evaluation survey will be completed in the next six months.
The opportunity to truly understand how and why PPE is necessary may fall on the next
generation of nurses. Annual PPE learning modules, unit culture changes, online resource tools,
and trained staff champions are vital components of a culture of safety in the AIC. The
implications for advanced practice nursing include educating all nurses on environmental risks
and increasing awareness of the consequences of non-compliance associated with social justice.
Finally, when an organization employs oncology infusion nurses, PPE use must be demonstrated,
enforced, and viewed as a critical function of everyday responsibilities.
Interpretation
Clark et al. (2014) discussed the role that organizations play in influencing employee
behavior regarding safety climate and citizenship behavior. Providing consistent messaging
about HD exposure on health, reinforcing safe-handling behaviors, and ensuring the availability
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of resources improved the basic understanding of handling toxic agents with care. He et al.
(2017) recommended removing barriers, such as modifying the nurses’ workload and
environment of care. During the weeks after the PPE intervention and toolkit introduction,
changes were made to the scheduling templates, thereby reducing patient to nurse staffing ratios.
The number of patients assigned to one nurse decreased from 10 to 12 patients per shift to six to
eight patients per shift. Nurses felt that this change allowed for more quality time with patients
and provided more opportunities to don PPE during each encounter, if needed. In addition, an
acuity rating for each therapy was adjusted that identified how patients would be divided
amongst the nurses. The average acuity ranges for therapies assigned to one RN dropped from 20
to 25 points per 10-hour shift to 15 to 20 points per 10-hour shift. One hour was left available in
each morning schedule to accommodate add-ons and unit-of-service changes based on patient
status.
Despite the availability of PPE and new standards, best practice does not always produce
the intended results. Optimal levels of compliance and adherence were only achieved for a brief
period due to an enhanced focus on the process measures. It truly highlights the importance of
training and education, role modeling, and providing data to support a task that is unpleasant and
whose results have not been quantified at this time. Also, competing priorities, such as the PPE
diversion to critical areas of need during the pandemic, may have delegitimized the need for
safe-handling measures in the AIC setting. Changing the rules for PPE use during COVID-19
may have also reinforced preconceived ideas held by AIC nurses that one problem is more
important than the other. The difference, in this case, is that the virus exposure cases were
measured continuously and reported publicly, while HD exposure incidents are rarely discussed.
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The Orem model of nursing or self-care deficit nursing theory was useful in evaluating
the progress and outcomes of the project and is widely adopted in the current organization’s EBP
culture. Conceptually, the context was explored by completing an assessment of the organization
and the AIC’s systems of care and discovering the variances between the needs and expectations
of the macrosystem and microsystem. The culture of safety and contributing factors were
evaluated to investigate any mitigating concerns and to understand the systems-thinking process
fully. Current scientific literature was reviewed to determine its applicability to the unit, and key
stakeholders were identified to act as project facilitators and project advocates. Orem’s model of
nursing provided an excellent conceptual framework for reviewing the evidence, context, and
facilitative leadership gaps that impeded the ability for nurses to provide safe handling of HDs,
as well as guided the translation of evidence that contributed to the toolkit’s final development.
Donabedian’s model was used to examine the AIC environment and to assess the quality
of care issues (McDonald et al., 2007). In this intervention, exploring the components of this
framework (structure, process, and outcomes) led to a better systems-thinking approach and to
the implications and influence the project had for other AICs. Again, in Donabedian’s
framework, the AIC concept of structure is associated with the organization’s characteristics of
the physical infusion center space, while the process involves the actual services provided to
oncology infusion patients. The outcome is the result of those measures. Relative to participants,
most were 40 to 59 years of age, certified in chemotherapy administration, and possessed a
bachelor’s degree in nursing. The hospital only hires nurses with a bachelor’s degree or higher;
however, nurses who were employed greater than 10 years who earned a diploma or associate
degree in nursing continue working at the facility. By the end of the QI project, new scheduling
templates decreased the patient volume and balanced the patient acuity from 10 to 12 patients per
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day to six to eight patients per day. The resource toolkit was added in the resource library under
the heading “Hazardous Drugs” on the intranet site, which is accessible to all nurses throughout
the healthcare system.
Nursing educators should include environmental and occupational health courses in the
core curriculum to teach about the risk of HD exposure. The role of the DNP has been significant
in educating nurses in the AIC through the use of an HD toolkit on environmental hazards
associated with HD exposures. The DNP, as a clinician and clinical nurse leader, has a distinct
role in presenting EBP strategies and how they might influence care in the AIC setting. Through
leadership, the DNP has established solid systems-thinking relationships with critical
stakeholders and facilitators that enabled the positive progression of shared responsibility with
HD handling. As an advocate, the DNP seeks to improve the long-ignored quality and safety of
AIC nurses. Through scholarship, the DNP reviews the literature for applicability to the care
setting, identifies gaps between oncology research and practice, and explores potential solutions
that promote the safest care possible for staff, patients, and their families. The DNP, as an
innovator, must evaluate the macrosystem and implement practice improvement that
complements the needs, mission, and values of the organization. As an educator, the DNP
teaches others about the significance of a problem and the reason change is required. The
educator role also offers evidence-based recommendations for the clinic based on results from
current or historical landmark studies concerning HD safety.
Limitations
There were several limitations to this QI project. The survey only pertained to one AIC in
one organization with a small sample size (N = 10) of experienced oncology infusion nurses. A
multi-center approach would increase the value of the findings related to PPE adherence in AICs.
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There is also a potential for lack of inter-rater reliability, given that the nurses were evaluated
multiple times on different days by different observers during the collection of data with the PPE
observation tool. The nurses who completed the self-assessments may have been different from
the ones who were being observed each day. Staff were reluctant to participate because they did
not want to perform the full PPE requirements.
The enforcement of PPE use was not part of the unit’s culture of safety, and most of the
nurses were long-time employees who objected to wearing PPE. It took three separate attempts
to get the initial survey completed because of the lack of interest in changing behavior. All
nurses had a current Chemotherapy and Biotherapy Administration card and were aware of the
best practice guidelines for wearing PPE with HD administration. The change in behavior relied
upon the USP <800> standards and HD policies as the driving force for improving compliance
and adherence. The resource toolkit provided instructions on how to achieve and measure those
desired outcomes.
Before the intervention, several concerns were identified: (a) nursing staff did not wear
PPE other than a single pair of chemotherapy-tested gloves; (b) most nurses had worked together
since the center opened more than six years ago and did not want to wear PPE; (c) nurses
indicated that PPE was only a recommendation, so it was a nurse’s choice; and (d) lack of
adequate PPE supplies. The DNP student utilized a systems-thinking leadership approach and
met with housekeeping, central supply, cancer committee leadership, and others to procure the
items required for the safe delivery of HDs. A PPE cart was set up, and plans were made to
restock items each morning. New HD waste bins with larger openings were ordered and placed
strategically in the unit for ease of chemotherapy waste disposal. Faucets were replaced to
accommodate three eye wash stations. Additional sharps containers were provided in each
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treatment pod, and staff participated in choosing the location for each new item. The DNP
student also worked with the information technology department to discuss the possibility of
whether an HD toolkit could be included in the current workflow area labeled “Hazardous
Drugs” on the systems’ intranet under “Resources.”
Conclusions
This project has multiple implications for future QI projects. Information associated with
a personal motivation for compliance and adherence with safe-handling standards needs to be
studied. This is especially significant since the HD toolkit is only as good as the motivation
required by nurses to search for information on proper PPE choices. The project suggests that
despite the high potential for HD residue exposure, staff perceptions about personal risks for
contamination remain low, and even information about HD precautions on demand did not
change how nurses comply or adhere to evidence-based knowledge. Clinically, the best options
are to determine which barriers exist that prevent optimal safe handling from occurring and
eliminate or minimize them in every situation. Also, by reducing the volume of patients treated
by a single nurse in a shift, it would be interesting to know if this factor alone could increase PPE
use and minimize exposure risks. The organization’s motivating efforts to educate and inform
staff of potential HD exposure lies in the enforcement of the USP <800> standards and other
regulations it is now required to uphold. Many nurses felt that the organization’s position on the
safe handling of HDs was evolving and that current guidelines met their safety expectations.
More efforts are needed to collect and disseminate national exposure risk data to share the
magnitude of this problem.
As the population of cancer patients and survivors grows, AICs will be challenged to
improve the quality and safety of their work environments and reduce the occupational risks of
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HD exposure. More focus on outpatient settings regarding safety processes and more efficient
methods to share critical information is needed. The focus on modifying the work environment
to improve safety by establishing HD toolkits as resources, the innovative development of
environmentally-safe PPE, and mandatory HD policies must be established, in combination with
a systems-thinking approach, to solve these multi-layered gaps in quality and safety. This clinical
intervention demonstrates that data showing the risks associated with HD exposure on HCWs are
sorely needed to make a case and to change risky behavior with PPE handling during
chemotherapy administration.

USP <800> AND THE PPE PROJECT

34

Section VI. Other Information
Funding
Long Beach Memorial Medical Center and the Todd Cancer Pavilion Cancer Committee
executive director and other staff members funded this QI project. There were no other funding
needs required for the project.
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Appendix A
Evidence Table

Citation
Bohlandt et al.
(2017)

Boiano et al.
(2014)

Statistical Tools

Data Collected

Wipe samples/surface
monitoring, urine collection,
questionnaire on household.
Analyses carried out under
strict internal and external
quality assurances;
SPSS Version 21;
Spearman rank correlation
test/Mann-Whitney-U test for
independent variables.

Setting: Patient homes s/p
chemo admin
Sample:
1) 265 wipe samples/13
homes at two times after
chemo from common
household surfaces.
2) 62 urine samples from
patients and family members
on three days.
3) Drugs analyzed:
cyclophosphamide (CP), 5fluorouracil (5-FU), and
platinum (PT).
Time Frame: Up to 4 days
Results: Substantial
contamination on every
surface type (PT: 0.02-42.5
pg/cm2; 5-FU: ND
98.3pg/cm2; CP: ND-283.3
pg/cm2)
Setting: NIOSH web-based
survey
Sample: 98% of 2,069
respondents were nurses
Time Frame: Jan 28 to Mar
29, 2011
Results: The survey results
show deficiencies related to

NIOSH Survey of Healthcare
Workers (an anonymous,
multi-module, web-based
survey), SAS 9.3 to analyze
data.

Quality of Evidence
Level: I
Quality: A
Limitations:
Spot samples, both wipe and
urine samples, only reflect the
current situation and that
probably different results may
have been found when
performing continuous urine
collection.

Highlights from Article
Aim: To evaluate the surface
contamination and the
potential uptake of
antineoplastic drug residues
by family members at home
of chemotherapy patients.
Exposure was evident in
patient homes on various
surfaces. Adequate hygienic
and protective measures are
necessary to minimize the
exposure risk for cohabitants.
Elevated levels in patient’s
urine more than 48 hours, no
drug residues in family
members’ urine.

Level: I
Quality: A
Limitations:
Survey was targeted to
members of professional
practice organizations and are
not generalizable to all

Authoritative guidelines are
not being universally
followed.
Activities that increased
exposure risk per
respondents, included: failure
to wear nonabsorbent gown
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the lack/infrequency of
training, awareness of
employer procedures, and
awareness of national safehandling guidelines.
Multiple breaches in safe
work practices (CSTDs, luerlick fittings, needleless
system).

Callahan et al.
(2016)

Descriptive, cross-sectional
correlational design study.
Survey Hazardous Drug
Handling Questionnaire.
Data were analyzed using
descriptive statistics and
multiple regression analysis.
(main research variables:
exposure knowledge, selfefficacy, perceived risk,
interpersonal influences, and
workplace safety climate).
Survey Monkey software
database, SPSS V21.0,
Spearman’s correlation
coefficients,
Wilcoxon rank sum tests.

Setting: The National
Institutes of Health Clinical
Center in Bethesda, Maryland
Sample: 196 eligible/115 RNs
working on high-volume HD
administration units.
Time Frame:
Results: Total mean HD
precaution use proved highest
during HD administration and
lowest for handling excreta at
48 hours. Average patients
per day significantly
influenced total HD
precaution: more precaution
use with fewer patients
assigned.

healthcare workers or to all
members of each of the
participating professional
organizations.
The survey was only
available to members with
email addresses and internet
access.

Level: II
Quality: A
Limitations:
Self-report survey conducted
in one specialized research
hospital and cannot be
generalized without
replication to other settings.
Nurses were required to
attend formal training to
administer chemo and
biotherapy and gain oncology
nursing certification

with closed front and tight
cuffs (42%), IV tubing
primed with antineoplastic
drug (6%) or by pharmacy
(12%), potentially
contaminated clothing taken
home (12%), gloves (12%),
lack of hazard awareness
training (4%).
Most common reason for not
wearing gloves or gowns was
“skin exposure was minimal,”
but respondents reported skin
contact during handling and
administration.
Purpose: To identify factors
associated with oncology
nurses’ use of HD safehandling precautions in
inpatient clinical research
units.
Data were analyzed using
descriptive statistics and
multiple regression analysis.
(main research variables:
exposure knowledge, selfefficacy, perceived risk,
interpersonal influences, and
workplace safety climate).
Conclusions: Despite high
exposure knowledge, barriers
to PPE use and conflict of
interest may contribute to
reduced adoption of personal
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Clark, et al.
(2014).

Occupation-specific field
study investigation to
understand the relationship
between safety climate and
employees’ organizational
citizenship behavior.

Colvin et al.
(2016).

Prospective, mixed-methods
study to compare objective
and subjective nurse
behavior, micro-ethnography
and questionnaires.
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Setting: 2 hospitals in the
Midwestern United States.
Sample: Focal nurses and
their peers using paper
surveys. 700 nursing
professionals
Timeframe:
Results: The correlation
between perceptions of safety
and organizational citizenship
behavior among nurse was
good when role definitions
were narrow but non-existent
when broad.
Setting: Cleveland Clinic
Sample: 22 cases of chemo
handling observed, 12 of 33
nurses completed
questionnaires.
Time Frame: Jan 2012 to Mar
2013
Results: Data analysis
involved describing the nurse
skill checklist frequencies and
self-assessment of RN
characteristics using medians
and quartiles of counts and
percentages for all categorical
variables.

Level: IIIA
Quality: A
Limitations:
Because nurses were able to
choose their peers, there may
have been positive bias due to
interpersonal familiarity.

Level: III
Quality: A
Limitations:
Study conducted in a single
center, and the sample size
was small.
Sample size for nurse
observations was small.
Lack of uniformity in
assessment item working
could have led to differences
in reported frequencies in
adherence to PPE
recommendations. One nurse

protective practices among
oncology nurses.
Hospitals and unit-specific
factors captured by the
predictor variables could
contribute to institutional HD
policy.
Safety climate appears to be
an important predictor linked
to employee performance.
Management must play an
important role to ensure
employee safety. By working
together, the quality of patient
care and safety increase and
outcomes improved.

The aims of the pilot study
were to examine actual and
subjective ambulatory
oncology nurse adherence to
chemotherapy safe handling
with NIOSH PPE and
hospital policy exposure
controls.
Consistent adherence to
practice expectations may
require more than an annual
competency assessment.
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Connor et al.
(2014)

Literature search using the
following databases:
• Canadian
• CINAHL
• CISILO
• DTIC, Embase
• Healthy and safety
abstracts
• HSELine
• NIOSHTIC-2
• OSHLine
• PubMed, Risk
abstracts
• Toxicology Abstracts
• Toxline, Web of
Science
• WorldCat
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Setting: Literature review
Sample: 18 peer-reviewed,
English language publications
of occupational exposure and
reproductive outcomes
studies.
Time Frame: Literature
review completed 1980 to
February 2014
Results: While effect sizes
varied with study size and
population, occupational
exposure to antineoplastic
drugs appear to raise the risk
of both congenital
malformations and
miscarriage. Studies of
infertility and time-topregnancy also suggested risk
for sub-fertility.
Measurement of surface
contamination is the best

may have been observed
more than once on different
days. Nurses observed had
two or more years nursing
experience in oncology
nursing and may not have
been well matched in the
group comparisons.
Analyses were based on
group findings; no
correlations were noted
between observed behaviors
and self-assessment by
individual nurses.
Level: III
Quality: A
Limitations:
Small sample sizes
5/8 studies had 10 or fewer
exposed cases. All studies
had fewer than 20 exposed
cases. Limited ability to
adjust for confounding; the
need to group anomalies that
had different etiologies and
wide confidence intervals,
which reflect poor statistical
power.

Chemotherapy exposure is a
team concern in that one
healthcare clinician can
follow all policies, yet still be
exposed to chemo if others
fail to do so.

Antineoplastic drugs are
highly toxic in patients
receiving treatment and
adverse reproductive effects
have been well documented
in these patients. HCW with
chronic, low-level
occupational exposure to
these drugs also appear to
have an increased risk of
adverse reproductive
outcomes. Additional
precautions to prevent
exposure should be
considered (NIOSH).
Some studies have shown an
association between surface
contamination and worker
exposure.
For pregnant women, the
window of risk begins one
month before conception and
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Connor et al.
(2016)

Crickman &
Finnell (2016)

Not stated

Databases searched:
• PubMed
• CINAHL
• Cochrane Library
• EMBASE
English language
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indicator of the level of
environmental contamination
in areas where Ads are
prepared, administered to
patients, or otherwise handled
(such as receiving areas,
transit routes throughout the
facility, and waste storage
areas).
The odds ratio of adjusted
models ranged from 1.36
(95% CI, 0.59-3.14) to 5.1
(95% CI, 1.1 -23.6)
Setting: Article review by
experts at NIOSH
Sample: not stated
Time Frame: not stated
Results:
A comprehensive safehandling program for ADs
may utilize wipe sampling as
a screening tool to evaluate
the environmental
contamination and strive to
reduce contamination levels,
as much as possible, using the
industrial hygiene hierarchy
of controls.
Setting: Systematic literature
review
Sample: 29 publications met
final review criteria
Time Frame: 1979 to 2014
Results: 5 major strategies
identified (engineering
controls, PPE, medical and

lasts through pregnancy (most
vulnerable in first trimester).
Breast milk is affected by HD
exposure.
A man’s sperm is vulnerable
to HDs from as early as 2
months before conception.

Level: III
Quality: A
Wipe sample area
recommendations:
Nurses’ station storage area
for IV bags
Countertops
Furniture in patient rooms
Infusion pump
Door handles, door knobs,
other high-touch areas
Computer keyboard/mouse
Floor in patient room
Floor in restroom
Level: III
Quality: A

The purpose of the article was
to review published studies of
wipe sampling for
antineoplastic and other HDs,
to summarize the methods in
use by various organizations
and researchers, and to
provide some basic guidance
for conducting surface wipe
sampling for these drugs in
healthcare settings.

The systematic review was
conducted to identify
evidence-based strategies for
protecting all HCWs, from
those involved in handling
packaged HDs to those who
dispose of body fluids of
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environmental monitoring,
hazard identification, need for
comprehensive HD control
program that includes
education and training for
HCWs).
Transparency in every step in
the chain of custody is
needed. Clear signs or labels,
including electronic
identifiers, and clear
instructions that prompt what
to do next are needed.

DeJoy et al.
(2017)

Data came from the 2011
NIOSH Health and Safety
Practices Survey of
Healthcare Workers, an
anonymous, multi-module,
web-based survey.
Statistical analyses were
performed using SAS 9.4
software in three stages: (1)
descriptive analyses, (2)
factor analysis of safety
perception, and (3)
psychometric analyses.

Setting: Online survey
Sample: Nurses (N=1,814)
who had administered IV
HDs in the 7 calendar days
prior to the survey and whose
employer was either a
hospital or ambulatory
healthcare center.
Time frame: Survey was
available for 8 weeks.
Results: The study showed
lower likelihoods of exposure
when staffing and resources
were adequate and when

individuals taking these
medications.
One problem with wipe
testing is that there is no
minimum acceptable
exposure level for
chemotherapy or other HDs.
Testing workers’ urine/blood
samples may be difficult to
operationalize across large
healthcare systems. Financial
and ethical implications must
be considered, specifically
with how to counsel staff
members with positive results
of urine or blood samples.

Level: III
Quality: A
Limitations:
• Cross-sectional study limits
the ability to make causal
interpretations.
• Survey respondents were
solicited from membership
rolls of professional
organizations and may not
represent all nurses who
administer HDs.

Barriers such as
understaffing, the physical
layout of a unit, and time
constraints can negatively
impact adherence.
Purpose/Objectives: To
examine predictors of the use
of PPE and engineering
controls and adverse events
involving IV HDs in a
relatively large and diverse
sample of nurses.
The study examined the
effects of pertinent
organization safety practices
and perceived safety climate
on the use of PPE,
engineering controls, and
adverse events (spill/leak or
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orders and doses were
consistently verified by two
nurses.

• The sample was limited to
nurses working in the U.S.
• Data collected were
analyzed at the individual
level.
• The collected data were
self-reported/could not
eliminate bias.

skin contact) involving liquid
antineoplastic drugs.
14% of nurses reported an
adverse event.
Results point to the value of
implementing a
comprehensive health and
safety program that uses
available hazard controls and
effectively communicates and
demonstrates the importance
of safe-handling practices.
Such actions also contribute
to creating a positive safety
climate.
Having an adequate
knowledge of risks does not
automatically produce
commensurate precautionary
action.

Friese et al.
(2019)

Methods & variables:
1. Revised Drug Handling
Questionnaire (Martin &

Setting: 12 ambulatory
oncology settings in the
United States. 15 sites were

Level: I
Quality: A
Limitations:

PPE use was lower among
nurses working in ambulatory
infusion centers and be
caused by less formalized
safety programs and perhaps
less direct supervision of
those administering HDs.
Both of these factors could
lead to diminished adherence.
Purpose/Objectives: To
evaluate whether a web-based
intervention improved PPE

USP <800> AND THE PPE PROJECT

Larson, 2003; Polovich &
Clark, 2012)
2. Practice Environment Scale
(Friese, 2012).
3. Safety Organizing Scale
(Vogus & Sutcliffe, 2006)
4. The authors measured
knowledge of HD handling
using a team-generated, pilottested, 10-item questionnaire.
5. Occupational Dermal
Survey to measure perceived
risk (Geer, Curbow, Anna,
Lees, & Buckley, 2006).
In a cluster randomized
controlled trial, 136 nurses in
control settings received a
one-hour educational module
on PPE use with quarterly
reminders, and 121 nurses in
treatment settings received
the control intervention plus
tailored messages to address
perceived barriers and
quarterly data gathered in HD
spills across all study settings.
The primary outcome was
nurse-reported PPE use.
The primary outcome was
PPE use, as measured by the
previously published Revised
Drug Handling Questionnaire
(Martin & Larson, 2003;
Polovich & Clark, 2012).
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eligible, but 3 declined
participating in study
12 sites were randomized
6 sites control arm
6 sites allocated to
intervention.
Sample: 396 nurses, 257 of
who completed baseline and
primary endpoint surveys.
Time frame: March 2015 to
March 2017
Results: Control and
intervention sites had
suboptimal PPE use before
and after the intervention. No
significant differences were
observed in PPE-use
knowledge or perceived
barriers. Participants reported
high satisfaction with the
study experience.

First, the study took place in a
convenience sample of
academic health centers with
high-volume cancer
programs. (Results may not
generalize to smaller or
community-based oncology
settings).
Second, the calculated
reliability of the outcome
measure in the current sample
was relatively low (0.46 for
the 3-item measure and 0.5
for the 5-item measure
considered in the sensitivity
analysis).

use among oncology nurses
who handle hazardous drugs.
Findings: It is clear that
education and engagement of
nursing personnel is not
sufficient to improve PPE use
– systematic approaches may
result in improved practice.
Conclusion: Despite four
decades of research, current
use of PPE remains
suboptimal in ambulatory
oncology settings. A theoryinformed, web-based
educational intervention to
RNs failed to improve PPE
use in the ambulatory
oncology setting.
A multi-faceted strategy
(equipment changes,
standardized policies,
educational efforts, and
leadership support) across
multiple levels (units,
hospitals, and health systems,
and professional
organizations) may be
required to improve
adherence to HD-handling
guidance.
Implications for Nursing:
HD exposure confers notable
health risks to healthcare

USP <800> AND THE PPE PROJECT

50

workers. To improve HD
handling, occupational
healthcare workers, health
systems, and professional
organizations should consider
coordinated efforts to
implement policy and
practice changes.
Other Data of Interest:
Future research efforts would
benefit from development and
testing of novel measures of
PPE use and evaluation of
optimal measurement times
after delivering educational
interventions and delivering
study reminders.
He et al. (2017)

1.Cross-sectional, multi-state
mailed survey to ONS
members (N=654)
Tool: Revised Hazardous
Drug Handling Questionnaire
(Martin & Larson, 2003;
Polovich & Clark, 2012)
2. Bivariate and multivariable
regression analyses
3. Covariates: nursing
workloads, nurses’ practice
environments, and barriers to
PPE use
4. Dillman’s total design
method to maximize response
rates (personalized cover
letters, $40 cash incentives,

Setting: Ambulatory
oncology practices in CA,
GA, and MI
Sample: 252 ONS members
who administer hazardous
drugs
Time frame: February to
September 2014
Results:
437 nurses completed surveys
(67% response). Final
analytical sample (n=252),
97% women, 79% 43 years or
older, 75% with at least 6
years of nursing experience,
and 96% worked in outpatient
oncology settings. The

Level: II
Quality: A
Limitations:
The internal reliability of the
dependent variable – the PPEuse scale – was lower in the
current sample (0.61) than
previously reported (Geer et
al., 2006).
The distribution of various
PPE (included on the PPEuse scale) had a bimodal
pattern; many respondents
reported either using PPE
very frequently or never.

Purpose/Objectives: To
examine patterns and
organizational correlates of
PPE use and hazardous drug
spills.
Findings: 26% reported
recent drug spill, 90% wore
only 1 pair of chemotherapytested gloves. PPE use was
associated with increased
nurse participation in practice
affairs, non-private
ownership, increased nursing
workloads, and fewer barriers
to PPE use. Spills were
associated with significantly
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three monthly reminders to
non-responders)
5. Safety Organizing Scale to
measure collective behaviors
performed by employees in
high-reliability organizations
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sample mean for the PPE-use
score was 2.4 (SD=1) out of a
maximum possible score of 5.

Other limitations included a
varying number of
respondents per practice (112 nurses) and missing data.
Roughly a third of practices
had only one nurse informant.
These limitations are
somewhat offset by the large
sample size, high response,
rate, and geographic
diversity.

less favorable manager
leadership and support and
higher workloads.
Conclusion: Drug spills occur
in ambulatory settings. PPE
use remains low, and barriers
to PPE use persist. Higher
workloads are associated with
more drug spills. As nursing
workloads increased by one
patient, the odds of HD spills
increased by 3% (OR=1.03,
95% CI [1.01-1.06], p=0.01).
Implications for Nursing:
Managers should monitor and
correct aberrant workloads
and ensure that PPE is
available and that staff are
trained.
Other Data of Interest:
The study findings
underscore the need to
improve individual adherence
through modifiable
administrative controls (e.g.,
commitments to safety
culture, improved nurse
practice environments,
thoughtful attention to nurse
workloads, deployment of
engineering controls).
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Hennessy &
Dynan (2014)

Hon et al.
(2014)

Framework for the Model for
Improvement (Langley,
Moen, Nolan, Norman, &
Provost, 1996), a continuous
process of tests of change,
performance measurement,
and feedback was put into
place to improve
performance.
Monthly audits with PPE
Observation Tool created by
Dana Farber educators.

Wipe samples analyzed for
cyclophosphamide (CP).
High-performance liquid
chromatography-tandem mass
spectrometry.
Active recruitment of
participants via letter of
invitation or telephone by
members of research team.
On-site surveys and selfadministration questionnaire.

52

Setting: Dana Farber Cancer
Institute
Sample: Infusion nurses in
ambulatory care
Time Frame: 2009-2014
Results: Previous compliance
rates 30%-40%
Key components of the
sustained success of this
initiative are staff education
and ownership of the required
changes, peer-performance
monitoring, leadership
support and prioritization of
the work, staff involvement in
product review and selection
of the PPE, and continuous
monitoring and feedback
regarding performance.
Setting: 5 hospitals and 1
cancer treatment facility
Sample: 115 participants/110
supplied duplicate hand wipe
sampling. Staff working in
the process of flow of drug
within a facility from initial
delivery to waste disposal
(8 groups of workers
identified).
Time Frame: not stated
Results: 225 wipe
samples/20% (n=44) were
above the limit of detection
(LOD) of 0.36ng per wipe.
Average concentration per

Level: III
Quality: A

A program was developed
that incorporated not only
monitoring and reporting
compliance of the use of PPE,
but also engaged the staff in
audit and reporting activities.
Compliance rates improved
dramatically over time and
have remained at high levels.
The goal was to improve
compliance with established
standards and hospital policy
regarding PPE use by nurses
administering chemo in the
outpatient setting.

Level: I
Quality: A
Limitations:
Unable to recruit
housekeepers into study
because the contract company
that employs housekeepers
declined to participate.
The findings are only
representative of the point in
time when samples were
collected.
Samples were based on
convenience sampling, which
allowed assessment of

The purpose of the study was
to determine the dermal
contamination levels of
healthcare employees
working throughout the
hospital and to identify
factors that may influence
dermal contamination.
All worker categories had
some level of dermal
exposure. Highest level of
dermal exposure was in
administration units who
were not responsible for drug
administration (volunteers,
oncologist, aide, dietician).
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Kang et al.
(2017)

Lawson et al.
(2019)
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wipe 22.8ng per wipe. (SD
1.98).

exposure throughout the day,
but does not allow
comparison to task-based
exposure levels.

Observational, descriptive
study in 4 parts: a simulation
observation, a survey (for
both clinical and sim
participants), and a follow-up
evaluation simulation.

Setting: University of
Pittsburgh
Sample: 82 HCP, 65 HCP
(72.93%; including 3 HCP
who participated in the
clinical observation). 97%
had at least 1 instance of
contamination during the PPE
doffing process in 2 sim
sessions with a simple set and
a full-body set. For 130
simulations, the
contamination rate was 79%
(n=103)
Time Frame: August 31September, 2015
Results:

Level:
Quality:

Self-report questionnaire for
pregnant nurses (within first
20 weeks) and non-pregnant

Setting: Online study
Sample: 40,000 nurses
participating in the Nurses’

Level: II
Quality: A

Limitations:
High likelihood of Hawthorne
effect. Because convenience
sample of study participants
and PPE items from one
health care system were
adopted, these findings may
not be generalizable to other
clinical settings.
Camera lens and lighting may
not have captured all
contamination.

Limitations:

Regardless of whether or not
a worker received safe drug
handling training, the
proportion of samples above
LOD was the same.
Very little is known about
how healthcare personnel
actually use PPE.
Evidence shows that
traditional learning methods
(e.g., watching educational
videos, learning PPE
guidelines) are inferior to
immersive learning methods,
including active learner
involvement using
simulations that include
feedback on performance.
Contamination breaches
appear to be associated with
poor HCP PPE techniques,
knowledge deficits, and
behavior flaws.
The study emphasized the
need for refining PPE
protocols based on further
scientific evidence,
reinforcing PPE training
using innovative methods,
improving and standardizing
PPE equipment for targeting
HCP optimal use.
The purpose of the study
assessed glove and gown use
by female pregnant and nonpregnant nurses who
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nurses (within the last
month).
Baseline NHS3 questionnaire.

Yuki et al.
(2013)

Urine and wipe samples from
patient and family members
inside homes.
Gas chromatography in
tandem with mass
spectroscopy-mass
spectroscopy or by highperformance liquid
chromatography with
ultraviolet-light detection.
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Health Study born on or after
January. 1, 1965
Time Frame: Started in 2010
and is ongoing
Results:
12% of non-pregnant
nurses/9% pregnant nurses
indicated they never wore
gloves with HD admin,
42%/38% never used a gown,
32% who crushed HD pills
did not wear gloves.
Mean age/non-pregnant = 37
years (SD 7.26)
Mean age/pregnant = 29.5
years (SD 4.05).
Setting: 3 patient homes
Sample:
Time Frame:
Results: 35 and 16 urine
samples were collected from
the three patients and their
family members. Drugs were
detected in all samples.
Cyclophosphamide (CP) in 8
of 12 samples 5-FU exposure
below the limit of detection.

Did not collect info on the use
of double versus single
gloves, engineering controls,
training of safe-handling
practices, and reasons or
barriers for not following
safe-handling
recommendations.
No information on nurse
specialties of respondents.
No info on facility type or
size, which might affect
training personnel.

administer antineoplastic
drugs in the U.S. and Canada.

Level: I
Quality: A

Purpose: To measure the
urinary excretion of Ads of
three patients during 48 h
after the admin of
cyclophosphamide (2
patients) and 5-FU (2
patients)

Limitations:
Sample size small

Findings underscore the need
for further training and
education to ensure that both
employers and nurses
understand the risks involved
and know which precautions
will minimize such
exposures. Adequate time
must be allowed for worker to
handle these drugs safely.

Home exposure was
demonstrated. Findings
indicate the importance of
strict precautions by the
members of treated cancer
patients, as well as healthcare
workers, to reduce exposure
to Ads.
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Appendix B
IRB from Site
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Appendix C

Letter of Approval from Immersion Site
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Appendix D
Gap Analysis

1. Nurses had no knowledge of the new USP <800> standards for healthcare
organizations and the PPE mandates for hazardous drug handling and administration.
2. Most nurses were oncology-certified RNs and understood the need for wearing PPE,
but did not feel the urgency of self-protection.
3. Current RN staffing levels for chemotherapy administration for a 10-hour shift was
one RN per 10 to 12 patients, which should have been six to eight patients only.
4. Current patient acuity levels for one RN scheduled for 10 hours was between 20 to 25
points (points assigned per therapy) instead of 15 to 20 points on average.
5. The PPE stored on the unit was suboptimal and dependent upon staff calling central
supply to restock items.
6. The compliance level for donning PPE was less than 10% prior to the implementation
of the quality improvement project.
7. The structural design of the infusion center limited the ability for easy access to PPE in
all chemotherapy treatment areas.
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Appendix E
Gantt Chart
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Appendix F

Work Breakdown Structure
USP <800> Compliance: A Hazardous Drug Safe-Handling Toolkit for Infusion Nurses

LEVEL 1
1 PPE Toolkit
Implementation
in Ambulatory
Care

LEVEL 2
1.1 Initiation

1.2 Planning

1.3 Execution

1.4 Control

1.5 Close-out

LEVEL 3
1.1.1 Evaluation and Recommendations
1.1.2 Develop Project Charter
1.1.3 Deliverable: Submit Project Charter
1.1.4 USP<800> Committee Reviews Project Charter
1.1.5 Project Charter Signed/Approved
1.2.1 Create Preliminary Scope Statement
1.2.2 Determine Project Team
1.2.3 Project Team Kickoff Meeting
1.2.4 Develop Project Plan
1.2.5 Submit Project Plan
1.2.6 Milestone: Project Plan Approval
1.3.1 Project Kickoff Meeting
1.3.2 Verify & Validate USP <800> PPE Requirements
1.3.3 Develop/Organize HD PPE Toolkit
1.3.4 Decide on Specific Type/Amount of PPE per unit
1.3.5 Testing Phase in Ambulatory Infusion Center
(AIC)
1.3.6 Completed Toolkit Introduced in AIC
1.3.7 Staff Training
1.3.8 Go Live
1.4.1 Project Management
1.4.2 Project Status Meetings
1.4.3 Risk Management
1.4.4 Update Project Management Plan
1.5.1 Audit Procurement
1.5.2 Document Lessons Learned
1.5.3 Update Files/Records
1.5.4 Gain Formal Acceptance
1.5.5 Archive Files/Documents
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Appendix G
Work Breakdown Structure Dictionary
Level WBS
Code
1
1

Element Name

Definition
All work to implement the new toolkit in
Ambulatory Care Setting.

2
3

1.1
1.1.1

Personal Protective Equipment
(PPE) Toolkit Implementation in
Ambulatory Care
Initiation
Evaluation and Recommendations

3

1.1.2

Develop Project Charter

3

1.1.3

3

1.1.4

3

1.1.5

Deliverable: Submit Project
Charter
USP <800> Committee Reviews
Project Charter
Project Charter Signed/Approved

2

1.2

Planning

3

1.2.1

3

1.2.2

Create Preliminary Scope
Statement
Determine Project Team

3

1.2.3

Project Kickoff Meeting

3

1.2.4

Develop Project Plan

3

1.2.5

Submit Project Plan

3

1.2.6

Milestone: Project Plan Approval

2

1.3

Execution

The work to initiate the project.
Working group to evaluate USP <800>
General Chapter PPE requirements and
make recommendations for the
Ambulatory Care Setting.
Project Manager to develop the Project
Charter.
Project Charter is delivered to USP
<800> Committee designee.
USP <800> Committee Reviews Project
Charter.
The USP <800> Committee signs the
Project Charter which authorizes the
Project Manager to move to the Planning
Process.
The work for the planning process for the
project.
Project Manager creates a Preliminary
Scope Statement.
The Project Manager determines the
project team and requests the resources.
The planning process is officially started
with a project kickoff meeting which
includes the Project Manager, Project
Team and USP <800> Committee
designee.
Under the direction of the Project
manager, the team develops the project
plan.
Project Manager submits the project plan
for approval.
The project plan is approved and the
Project Manager has permission to
proceed to execute the project according
to the project plan.
Work involved to execute the project.
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1.3.1

Project Kickoff Meeting

3

1.3.2

Verify & Validate USP<800>
PPE Requirements

3

1.3.3

3

1.3.4

3

1.3.5

Develop/Organize HD PPE
Toolkit
Decide on Specific Type/Amount
of PPE per Unit
Testing Phase in Ambulatory
Infusion Center

3

1.3.6

3

1.3.7

Completed PPE Toolkit
introduced into Ambulatory
Infusion Center setting
Staff Training

3

1.3.8

Go Live

2

1.4

Control

3

1.4.1

Project Management

3
3

1.4.2
1.4.3

Project Status Meetings
Risk Management

3

1.4.4

Update Project Management Plan

2
3

1.5
1.5.1

Close-out
Audit Procurement
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Project Manager conducts a formal
kickoff meeting with the project team,
project stakeholders, and USP <800>
Committee designee.
The original USP<800> General Chapter
requirements for personal protective
equipment (PPE) use with hazardous
drug agents is reviewed by the Project
Manager and team, then validated with
the stakeholders. This is where additional
clarification may be needed.
The resources to design the new PPE
toolkit will be assembled.
The procurement of all PPE required for
the project.
Team creates a system for testing PPE
adherence and customizations of user
interfaces (Low, Moderate, High Risk)
with hazardous drug handling.
The actual PPE Toolkit is introduced into
the Ambulatory Infusion Center’s
workflow processes.
All staff are provided with a one-hour
training on donning and doffing of PPE.
Additionally, managers are provided
with a two-hour class to cover advanced
reporting.
System goes live with all Ambulatory
Infusion Center (AIC) staff.
The work involved for the control
process of the project.
Overall project management for the
project.
Weekly team status meetings.
Risk management efforts as defined in
the Risk Management Plan.
Project Manager updates the Project
Management Plan as the project
progresses.
The work to close out the project.
An audit of all measurement tools and
management plans procured for the
project, ensure that all procured products
are accounted for and in the asset
management system.

USP <800> AND THE PPE PROJECT

3

1.5.2

Document Lessons Learned

3

1.5.3

Update Files/Records

3

1.5.4

Gain Formal Acceptance

3

1.5.5

Archive Files/Documents
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Project Manager along with the project
team performs a “lessons learned”
meeting and documents the lessons
learned from the project.
All files, data, and adherence monitoring
tools are updated to reflect the completed
PPE Toolkit intervention.
The USP <800> Committee formally
accepts the project by signing the
acceptance document included in the
project plan.
All project related files and documents
are formally archived.
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Appendix H
Glossary
Ambulatory
Care Settings

Hazardous Drug
Agents (HDs)

Level of Effort
Personal
Protective
Equipment
(PPE)

PPE Toolkit

USP General
Chapter <800>
Scope (USP
<800>)

WBS Code

WBS
Component
WBS Element

Work Package

Ambulatory Care refers to medical services performed on an outpatient
basis, without admission to a hospital or other facility. Ambulatory care is
provided in settings such as dialysis clinics, ambulatory infusion centers,
ambulatory surgical centers, hospital outpatient departments, and the
offices of physicians and other health professionals.
In pharmacology, hazardous drugs are drugs that are known to cause
harm, which may or may not include genotoxicity (the ability to cause a
change or mutation in genetic material). These drugs can be classified as
antineoplastic, cytotoxic agents, biologic agents, antiviral agents and
immunosuppressive agents. The NIOSH criteria include: carcinogenicity,
teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low
doses, and drugs that mimic existing drugs in structure or toxicity.
Level of Effort (LOE) is how much work is required to complete a task.
Personal protective equipment is protective clothing, headwear, goggles,
gloves, shoe covers, respirators, or other garments or equipment designed
to protect the wearer’s body from injury, infection, or exposure to
hazardous agents. The hazards addressed by protective equipment include
physical, electrical, heat, chemicals, biohazards, and airborne particulate
matter.
A set of resources, interventions, and skills required to ensure staff
adherence to hazardous drug safe handling and compliance with USP
General Chapter <800> requirements for PPE selection and use during
transport, receivership, storage, preparation, administration, and disposal.
Protects any worker in contact with hazardous drugs or the patient
environment and includes, but not limited to; pharmacists; technicians,
nurses, physicians, physician assistants, nurse practitioners, home health
care, environmental services workers, engineering, anyone entering a
patient treatment area, pharmacies, hospitals, and other healthcare
institutions, patient treatment clinics, physician practices, and the public.
A unique identifier assigned to each element in a Work Breakdown
Structure for the purpose of designating the elements hierarchical location
within the WBS.
A component of a WBS which is located at any level. It can be a Work
Package or a WBS Element as there’s no restriction on what a WBS
Component is.
A WBS element is a single WBS component and its associated attributes
located anywhere within a WBS. A WBS Element can contain work, or it
can contain other WBS Elements or Work Packages.
A Work Package is a deliverable or work component at the lowest level of
its WBS branch.

USP <800> AND THE PPE PROJECT

64
Appendix I
SWOT Analysis

Strengths
• Expert Oncology Staff Resources

Weaknesses
• Room design and waste management not

• Infusion-Trained/Chemotherapy certified RN
Team
• Supportive Executive Leadership/Management
Teams
• Long-term Employees at the Facility committed
to quality improvement at all levels
• Teamwork between various
divisions/pharmacy/physician offices and
ambulatory infusion centers through focused
workgroups

practical for effective safe handling.
• Employee and environmental surveillance
inconsistently performed and costly.
• Policies and Procedures (P&P) reflect guidance
for PPE use, not mandatory (open to interpretation
by staff nurses)
• Unknown cost impact for meeting the USP
<800> Standards for PPE use.
• No system-defined comprehensive list of HDs,
and no risk assessment for all HDs.
• No Standard Work process for PPE utilization
with HD administration
• Beliefs and attitudes of nurses that PPE is a
personal choice.
• No audit tools to ensure compliance with USP
<800> Standards for PPE use.

Opportunities
• Increase in demand for ambulatory infusion

Threats

services across the country requires more
oncology-infusion trained nurses/may need to
partner with nursing schools to provide
exposure/hiring pool for future needs.
• Decrease the gap between leadership and
frontline infusion nurses to improve care delivery
and patient/nurse safety in the AIC
• Increase in the aging population with baby
boomers at Medicare age
• Increase all infusion nurses training on
chemotherapy/biotherapy/ infusion therapy for
future growth needs

• Unknown costs associated with PPE equipment,
environmental testing for residues, and health
monitoring of staff for HD exposure/no known
HD limits like radiation oncology practice.
• Maintaining and recruiting nurses to work in
high risk for exposure environment.
• Decrease in funding for infusion services with
21st Century Cures Act. Political climate related
to healthcare structural changes within the
political parties as to what changes will be
implemented
• Deadline extended for implementation of USP
<800> regulations.
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Appendix J
Responsibility / Communication Matrix

Who
Cancer Committee Members
Assistant Unit Manager (AUM) AIC

What
Evaluation and Recommendations
Develop Project Charter

Assistant Unit Manager (AUM) AIC

Submit Project Charter

USP <800> Committee

USP <800> Committee Reviews Project
Charter
Project Charter Approved

USP <800> Committee/Cancer Committee
Cancer Committee
NPs/Pharmacy/AUM/Clinical Nurse Educator

Create Preliminary Scope Statement

Assistant Unit Manager

Determine Project Team

Project Charter Team Members

Project Team Kickoff Meeting

Assistant Unit Manager (AUM)

Submit Project Plan

Cancer Committee Members/ Executive
Director Cancer Center
USP <800> PPE Group

Milestone: Project Plan Approval

Clinical Nurse Educator
Pharmacy Department
USP <800> Committee Representative

Verify & Validate USP <800> Requirements

Project Kickoff Meeting

How
Monthly at Cancer Committee meeting
Discuss project with leadership and ask for
recommendations of persons interested in
working on the PPE Project Team
Meet with interested people and gain buy-in
and have them help finalize the Charter and
AUM will send completed Charter to USP
<800. Committee
Present at USP <800> Committee meeting
and request approval from Project Sponsor
Committee will approve Charter and report
back to DNP team
Meeting with the group to discuss the needs
of the Cancer Center related to physician
practices/specialties
AUM to meet with interested persons and
select based on knowledge and skills related
to HD management and PPE knowledge
Arrange for meeting with group once Charter
has been approved via Skype or Zoom
sessions
AUM to assist team with project plan and
submit to USP<800> committee
Report back to Cancer Committee and gain
approval at next meeting
Notify PPE group of plans to set up meeting
by email and personal telephone calls
Check with OSHA, NIOSH, and USP<800>
Committee to confirm requirements for PPE
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Clinical Nurse Educator/ DNP Student (AUM
in AIC)

Develop/Organize HD PPE Toolkit

Clinical Nurse Educator/ DNP Student
Relief Charge Nurses in AIC/Central Supply
Department

Decide on Specific Type/Amount of PPE per
unit

Clinical Nurse Educator/DNP Student

Testing Phase in AIC

NPs, Pharmacist, AUM

Confidential Observations in AIC

Oncology MD, NPs, Pharmacist, OCN Nurse,
Oncology Nurse Educator, AUM

Educational Intervention by Panel

DNP Student/ Clinical Nurse Educator

Completed Toolkit introduced in AIC

RN Staff in AIC

Staff Training-Peer-to-Peer Review

All Staff in AIC

Go Live

Review current evidence regarding toolkit
resources for HD PPE/select tools/request
permission from owners of tools to use
Request items used for PPE and bring to unit
for evaluation by nurses/discuss preferences
and select type and amount needed for test
phase
Preliminary testing with one RC to determine
feasibility of project and to demonstrate
“Observation of PPE Tool” purpose and
planned confidential use
Audits over 2 weeks at random intervals by
practitioners, pharmacy, and AUM during
routine rounding in AIC
Select panel of experts to introduce HD
education and need for PPE/invite to
informational meeting about project
Review final Tools for the toolkit and get
approval from Executive Director and expert
panel members to proceed with
printing/preparing for intervention
Provide inservice during monthly staff
meeting to teach use of peer-to-peer review
tool for PPE during administration
Use huddle boards, email, and text reminders
of Go Live with PPE date
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Appendix K

Cost Benefit Analysis
Cost Benefit Analysis
Implementation of HD Safe-Handling Toolkit
Initial Implementation/Year 1/ 2020
Total Cost = $28, 950
Cost Avoidance x 1 year related to Workers Compensation Claims for Exposure x 1 nurse =
$37,540
Savings Year 1 = $8, 590
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Appendix L
Budget

Type of Expense
Staff Training on “Observation of PPE Use” Tool (NP,
CNL, Clinical Nurse Educator, Pharmacist) – 1 hour
Discussion
Staff Training on “Hazardous Drug Administration SafeHandling Checklist” Tool (1 Clinical Nurse Educator, 2
Relief Charge Nurse, 2 Pediatric Infusion Nurses, 2
Nurse Practitioners)
Expert Panel Discussion for All Staff Nurses
Staff Training estimate based on $75/hr. (15 nurses) 1
hour training during staff meeting
USP <800> Compliance: Hazardous Drug
Administration Toolkit for Infusion Nurses (Printing)
PPE Supplies including White Preparation Trays in
Medication Rooms
Average 5 RNs per day x 10 hrs. = 50 hours, Average
nurse # PPE changes per patient (5) x 15 PPE changes
per day
Hazardous Waste Bins for PPE and Medical Waste per
cubicle (35)
DNP Student/Assistant Unit Manager salary and time
Estimated Total

Cost
$75/hr. x 7 = $525

$75/hr. x 7 = $525

Complimentary Time from Cancer
Committee Budget $1200
$1,125
$1,000
$15 per PPE Kit x 15 changes/per
nurse/per shift = $210
x 5 nurses/per day =$1,050 per day x 7
days/week = $7350 per week
$35/waste bin x 35 cubicles = $1225
per week
215 hours at $80.00/hr. = $17,200
$28,950 + ($1200 in kind)
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Appendix M

Return on Investment

Avg. Indemnity
Claim/per
nurse/year
$37,540

10 Nurses
Exposed
$370,540

Over Three Years Average Claim
$1.1 million

(WCIRB, 2017)
Information based on the average California indemnity claim report for 2017 (Note: The average
claim in California is 40% higher than the median average nationwide and paid over three years.)

The return on investment is clear. Nurses who have been exposed to hazardous drug residues
may develop adverse health issues for many years and may require long-term follow-up to
manage the consequences of exposure. A program that instills the importance of an HD exposure
prevention strategy at a nominal cost is worth saving millions of dollars and minimizing the risk
of harm and protection of life.
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Appendix N
USF QI Approval

On File with the University of San Francisco
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Appendix O

Descriptive Tables
Table 1
Sample Characteristics
Demographic
Age (years)
Experience
Nursing
Oncology
Treatment volume
Patients per day
Education
Diploma
Associate’s degree
Bachelor’s degree
Master’s degree

M
44

SD
14.0

19
14
M
10
%
0
10
70
20

13.4
10.1
Mdn
10
N
0
1
7
2

Note. Mdn = median, SD = standard deviation, N = number of nurses.
Note. Fifteen surveys distributed, 10 RNs eligible, 3 RNs ineligible (< 2 years oncology experience), 1 RN on
maternity leave, 1 RN retired.
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Table 2
Nurses’ Self-Assessment of Adherence to PPE Use Results Summary (N = 10)
Question
Q1: Uses absorbent pad on work surface for chemotherapy agents.
Q2: Wears one pair of chemotherapy-approved gloves to remove
chemotherapy agents from transport bag.
Q3: Wears two pairs of chemotherapy-approved gloves to remove
chemotherapy agents from transport bag.
Q4: Removes outer gloves prior to programming pump.
Q5: Washes hands after removing gloves.
Q6: Wears second pair of chemotherapy-approved gloves over
ribbed cuff of gown.
Q7: Removes gown prior to leaving room.
Q8: Wears chemotherapy-approved gown, with first pair of
approved gloves under ribbed cuff.
Q9: Disposes of gloves in a chemotherapy-approved container after
initiating chemotherapy after disconnecting and discarding
chemotherapy agent.
Q10: Removes gown prior to leaving room after disconnection and
discarding chemotherapy.
Q11: Wears two pairs of chemotherapy-approved gloves and
chemotherapy-approved gown when handling chemotherapy.
Q12: Wraps gauze pad around connection site (CSTD) when
disconnecting chemotherapy tubing, leaving chemotherapy bag
attached.
Q13: Disposes of gloves in a chemotherapy-approved container.
Q14: Washes hands after disposal of gloves in the chemotherapyapproved container.
Q15: Discards the chemotherapy bag and attached secondary
tubing in chemotherapy-approved waste container.

Never
%
n
20
2

Rarely
%
n
0
0

Sometimes
%
n
20
2

Usually
%
n
10
1

Always
%
n
50
5

20

2

0

0

0

0

20

2

60

6

50

5

0

0

0

0

30

3

20

2

20
0

2
0

10
0

1
0

20
0

2
0

30
30

3
3

20
70

2
7

30

3

30

3

0

0

10

1

30

3

0

0

0

0

30

3

30

3

40

4

20

2

0

0

0

0

30

3

50

5

0

0

0

0

10

1

10

1

80

8

0

0

0

0

20

2

20

2

60

6

20

2

30

3

10

1

30

3

10

1

60

6

10

1

20

2

10

1

0

0

0

0

0

0

0

0

10

1

90

9

0

0

0

0

10

1

20

2

70

7

0

0

0

0

0

0

0

0

100

10
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Table 3
Observations of Chemotherapy Safe-Handling Adherence in Number of Events (N = 50)
Behavior
Handling and Administration
1. Uses absorbent pad on work surface for chemotherapy
agents.
2. Wears one pair of chemotherapy-approved gloves to
remove chemotherapy agent from transport bag.
3. Wears two pairs of chemotherapy-approved gloves to
remove chemotherapy agents from transport bag.
4. Removes outer gloves prior to programming pump.
5. Washes hands.
6. Wears second pair of chemotherapy-approved gloves over
ribbed cuff of gown.
7. Removes gown prior to leaving room.
8. Wears chemotherapy-approved gown, with first pair of
chemotherapy-approved gloves under ribbed cuff of gown.
9. Disposes of gloves in a chemotherapy-approved container
after initiating chemotherapy.
Disconnecting and Discarding
1. Removes gown prior to leaving room.
2. Wears two pairs of chemotherapy-approved gloves and
chemotherapy-approved gown when handling
chemotherapy.
3. Wraps gauze pad around connection site (CSTD) when
disconnecting chemotherapy tubing, leaving chemotherapy
bag attached.
4. Disposes of gloves in a chemotherapy-approved container.
5. Washes hands.
6. Discards the chemotherapy bag and attached secondary
tubing in chemotherapy-approved waste container.

Adherence (n)

Observation (n)

16

50

33

50

24

50

14
36

50
50

19

50

40

50

40

50

42

50

44

50

16

50

4

50

44
36

50
50

46

50
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Table 4
Differences between Nurses’ Self-Assessment of Adherence from Survey and Direct Observation
of Adherence

Behavior

Handling and Administration
1. Uses absorbent pad on work surface for chemotherapy
agents.
2. Wears one pair of chemotherapy-approved gloves to
remove chemotherapy agent from transport bag.
3. Wears two pairs of chemotherapy-approved gloves to
remove chemotherapy agents from transport bag.
4. Removes outer gloves prior to programming pump.
5. Washes hands.
6. Wears second pair of chemotherapy-approved gloves over
ribbed cuff of gown.
7. Removes gown prior to leaving room.
8. Wears chemotherapy-approved gown, with first pair of
chemotherapy-approved gloves under ribbed cuff of gown.
9. Disposes of gloves in a chemotherapy-approved container
after initiating chemotherapy.
Disconnecting and Discarding
1. Removes gown prior to leaving room.
2. Wears two pairs of chemotherapy-approved gloves and
chemotherapy-approved gown when handling
chemotherapy.
3. Wraps gauze pad around connection site (CSTD) when
disconnecting chemotherapy tubing, leaving chemotherapy
bag attached.
4. Disposes of gloves in a chemotherapy-approved container.
5. Washes hands.
6. Discards the chemotherapy bag and attached secondary
tubing in chemotherapy-approved waste container.

Nurses’ SelfAssessment of
Adherence
(N = 10
participants)
%

Direct
Observation of
Adherence
(N = 50 number
of events)
%

50

32

60

66

20

48

20
70

28
72

30

38

40

80

50

80

80

84

50

88

10

32

0

8

90
70

88
72

100

92
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Appendix P
Toolkit
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Appendix Q
Proposed CQI Method and Data Collection

Variable Name

Brief Description

Data
Source
Online
Survey

Self-Assessment
of Adherence to
PPE use

Nurses evaluate their own
personal competency skills
with adherence and
compliance with PPE
handling

Adherence

Observation/Self
Adherence
Pre-Intervention
Assessment for Adherence
by trained observers

Tool

Comparison Score
Sheet

Comparison Summary

Tool

Behavior

Project Data Collection
Tool to compare
Observation Adherence to
Self-Assessment
Adherence
Observation of infusion
nurses pre-administration,
administration, discarding
of hazardous drugcontaminated waste

Tool

Compliance with
hospital policy

Tool

Tools/Analyzing Data
Table 1: Sample
Characteristics
Table 2: Nurses’ Selfassessment of Adherence to
PPE Use (Hennessey &
Dynan, 2014)
Table 3: Observations of
Chemotherapy Safe-Handling
Adherence in Number of
Events
(Colvin, Karius, & Albert,
2016)
Table 4. Differences between
Nurses’ Self-Assessment of
Adherence from Survey and
Direct Observation of
Adherence
Table 5: Hazardous Drug
Administration Safe-Handling
Checklist (Peer-to-Peer
Feedback Tool)
Table 6: PPE Observation
Tool for Compliance with
Hospital Hazardous Drug
(HD) Safe-Handling Policy

Measurement
Type
15-item questionnaire that uses a
five-point Likert-type response
set ranging from 0 (never) to 4
(always)

Time
Frame
Two Weeks

Medians and Quartiles of counts
and percentages

Two Weeks

Percentage totals

N/A

Yes/No ( individual peer
feedback only)

N/A

Medians and Quartiles of counts
and percentages

Two Weeks
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Appendix R

Hazardous Drug Administration Safe-Handling Checklist (Peer-to-Peer Feedback Tool)
Nurse’s Initial:
Date of Review:
Pt. MR#:
PRIOR TO ADMINISTRATION
Yes
1. Gather equipment required for drug administration.
2. Select appropriate gloves for hazardous drug administration.
3. Select appropriate gown for hazardous drug administration.
4. Identify situations when mask and face protection are required.
5. Locate hazardous drug spill kit.
6. Obtain hazardous waste container.
ADMINISTRATION
1. Wash hands and don personal protective equipment (PPE) before opening
drug delivery bag.
2. Visually inspect the contents of the delivery bag for leaks.
3. Gather IV administration supplies including closed-system drug-transfer
devices (CSTD).
4. For IV infusions:
• Ensure tubing is primed with a nondrug solution.
• Utilize plastic backed absorbent pad under work areas. Remove cap
from IV tubing and connect to patient’s IV device.
• Utilize closed-system drug-transfer device when compatible.

No

Initials

•
•

5.

Tighten locking connections.
When complete, don PPE and discontinue IV bag with tubing intact
(do not unspike bag).
• Utilize gauze pads when disconnecting from patient’s IV device when
a closed-system drug-transfer device cannot be used.
For IV Push Medications
• Utilize closed-system transfer device when possible.
• Tighten locking connection.

• When complete, do not recap needle.
• Discard syringe-needle unit in puncture-proof container.
POST-ADMINISTRATION
1.

Don personal protective equipment.

2.

Seal hazardous drug-contaminated supplies in sealable plastic bag for
transport to hazardous waste container.
Place sealed plastic bag in hazardous waste container.
Remove outer gloves.
Close lid on waste container.
Decontaminate equipment in the area appropriately.
Remove and discard inner gloves.
Wash hands thoroughly with soap and water.

3.
4.
5.
6.
7.
8.

Reviewer Signature: _____________________________________Initials: _______________
Comments:
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Appendix S

PPE Observation Tool
For each observation, indicate “yes” for compliant with safe-handling policy or “no” if not compliant. If
“no”, check the corresponding box for a description of the failure to comply. More than one description
may apply to one observation (Hennessey & Dynan, 2014).
Location: AIC
Month/Year:
_____________2019
Observer:
________________________

#1
Yes
No

#2
Yes
No

#3
Yes
No

#4
Yes
No

#5
Yes
No

#6
Yes
No

#7
Yes
No

#8
Yes
No

Observation: Compliant with USP
<800> Hospital Policy
Observation type (checkbox)
Pre-Administration
• Handling bags or syringes
outside the leak-proof
transport bag requires gloves
and gowns.
• Handling the closed, zipped
leak-proof bag does not
require gown (gloves are
optional).
Administration
• Hanging, bags, attaching
tubing, administering IVP, IM,
SC requires gloves and gown.
Discard
• Take down of bags and tubing
that contain or contained
chemotherapy and discarding
syringes after IVP, IM, and
SC requires gown and gloves,
Description of Non-Compliance
• Wore no gloves
• Wore no chemotherapy gloves
• Wore non-chemotherapy
gloves
• Wore no gown
• Reused gown
• PPE gown worn in non-patient
care area
• Chemotherapy at desk or in
the non-patient care area
Additional Comments:
Observation #
IM - Intramuscular; IVP - Intravenous Push; PPE - personal protective equipment; SC - subcutaneous

#9
Yes
No

#10
Yes
No

